66200-70-2

Usage

Uses

Used in Research Applications:
2CT7 is utilized as a research chemical for studying the effects of psychedelic substances on the human brain. Its structural similarity to other hallucinogens allows scientists to explore its potential applications in understanding the mechanisms behind altered perceptions and thought patterns.
Used in Controlled Substance Regulation:
As a Schedule I controlled substance, 2CT7 serves as an example of the strict regulations in place to prevent the abuse and distribution of potentially harmful psychoactive substances. This classification helps to protect public health and safety by limiting access to substances with a high potential for misuse.

Upstream product

• 89-97-4 2-CHLOROBENZYLAMINE 
• 98-03-3 thiophene-2-carbaldehyde 
• 79442-72-1 (2-Chloro-benzyl)-[1-thiophen-2-yl-meth-(Z)-ylidene]-amine 

Downstream Products

• 79442-73-2 2-[(2-Chloro-benzyl)-thiophen-2-ylmethyl-amino]-1-(4-chloro-phenyl)-ethanone 
• 66200-73-5 6-o-Chlorobenzyl-4-p-methoxyphenyl-4,5,6,7-tetrahydro-thieno[2,3-c]pyridine 
• 79442-68-5 amino-2 (p-chlorophenyl)-1 ethanol 
• 66200-80-4 6-(2-Chloro-benzyl)-4-p-tolyl-4,5,6,7-tetrahydro-thieno[2,3-c]pyridine 
• 66200-72-4 amino-2 (p-methoxyphenyl)-1 ethanol 
• 66200-79-1 amino-2 (p-tolyl)-1 ethanol 
• 79442-75-4 aminomethyl (p-methoxyphenyl) cetone 
• 79442-74-3 aminomethyl (p-tolyl) cetone 

Relevant academic research and scientific papers

Nouvelles voies d'acces a des aryl-4 thienopyridines et a des aryl-7 thienopyridines

4-Arylthienopyridines and 7-arylthienopyridines have been prepared by heating in polyphosphoric acid 2-(2-thenylamino)-1-arylethanols or propanols and 2-(3-thenylamino)-1-arylethanols and propanols, respectively.Under the Beckmann rearrangement conditions, oximes of 4-aryl-4,5-dihydro-6H-cyclopentathiophen-6-one lead to 4-aryl-4,5-dihydro-6H-thienopyridin-7-one.

Thieno [2,3-c] and [3,2-c] pyridines

This invention relates to pyridine derivatives of the formulae: STR1 in which R1 is hydrogen, lower alkyl, aralkyl optionally substituted on the aromatic nucleus with at least a halogen atom or a hydroxy, nitro, amino, cyano, carboxy, alkoxycarbonyl, lower alkyl, lower alkoxy or trifluoromethyl group; R2 is hydrogen or lower alkyl; and R3 is hydrogen or at least a substituent selected from a halogen atom, a hydroxy, lower alkyl and lower alkoxy group, and their pharmaceutically acceptable inorganic or organic acid addition salts. Said compounds have particularly an anti-inflammatory and blood-platelet aggregation inhibiting activity.